Rifampin and clindamycin are safe long-term: Response to "North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations Part II: Topical, intralesional, and systemic medical management"
- PMID: 31568806
- DOI: 10.1016/j.jaad.2019.08.088
Rifampin and clindamycin are safe long-term: Response to "North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations Part II: Topical, intralesional, and systemic medical management"
Comment in
-
Reply to "Rifampin and clindamycin are safe long-term".J Am Acad Dermatol. 2023 Jan;88(1):e33. doi: 10.1016/j.jaad.2019.09.048. Epub 2019 Sep 27. J Am Acad Dermatol. 2023. PMID: 31568805 No abstract available.
Comment on
-
Long-term clinical safety of clindamycin and rifampicin combination for the treatment of hidradenitis suppurativa. A Critically Appraised Topic.Br J Dermatol. 2019 Apr;180(4):749-755. doi: 10.1111/bjd.17265. Epub 2018 Nov 25. Br J Dermatol. 2019. PMID: 30281779 Review.
-
North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I: Diagnosis, evaluation, and the use of complementary and procedural management.J Am Acad Dermatol. 2019 Jul;81(1):76-90. doi: 10.1016/j.jaad.2019.02.067. Epub 2019 Mar 11. J Am Acad Dermatol. 2019. PMID: 30872156 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
